Enovix Corp
For the period ended Jun 29, 2025. Filed Jul 31, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 29, 2025 · Filed Jul 31, 2025
ENVX$2.64-5.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows for the
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Fiscal Years-to-Date Ended | ||
|---|---|---|
| June 29, 2025 | June 30, 2024 | |
| Cash flows used in operating activities: | ||
| Net loss | $(67,797) | $(162,444) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation, accretion and amortization | 17,277 | 30,917 |
| Stock-based compensation | 26,136 | 31,797 |
| Changes in fair value of common stock warrants | (9,911) | 12,540 |
| Gain on bargain purchase of assets | (4,761) | — |
| Impairment and loss on disposal of long-lived assets | — | 35,107 |
| Others | 1,405 | 172 |
| Changes in operating assets and liabilities: | ||
| Accounts and notes receivables | (552) | 669 |
| Inventory | (5,410) | (771) |
| Prepaid expenses and other assets | 1,765 | (1,562) |
| Accounts payable | 2,241 | (8,250) |
| Accrued expenses and compensation | (5,001) | 3,465 |
| Deferred revenue | 1,044 | 299 |
| Deferred tax liability | (683) | (5,366) |
| Other liabilities | 1,481 | 1,434 |
| Net cash used in operating activities | (42,766) | (61,993) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | (14,243) | (40,297) |
| Payment for business acquisition | (10,000) | — |
| Purchases of investments | (85,473) | (31,812) |
| Maturities of investments | 18,627 | 91,621 |
| Net cash provided by (used in) investing activities | (91,089) | 19,512 |
| Cash flows from financing activities: | ||
| Proceeds from loan borrowing | — | 4,572 |
| Repayment of debt | (813) | (73) |
| Payroll tax payments for shares withheld upon vesting of RSUs | (2,853) | (3,315) |
| Proceeds from the exercise of stock options and issuance of common stock under ATM, net of issuance costs | 782 | 42,753 |
| Proceeds from issuance of common stock under employee stock purchase plan | 711 | 1,145 |
| Payments of transaction costs related to common stock issuance | (512) | — |
| Repurchase of unvested restricted common stock | — | (1) |
| Net cash provided by (used in) financing activities | (2,685) | 45,081 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (102) | (748) |
| Change in cash, cash equivalents, and restricted cash | (136,642) | 1,852 |
| Cash and cash equivalents and restricted cash, beginning of period | 274,691 | 235,123 |
| Cash and cash equivalents and restricted cash, end of period | $138,049 | $236,975 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
| Fiscal Years-to-Date Ended | ||
|---|---|---|
| June 29, 2025 | June 30, 2024 | |
| Supplemental cash flow disclosure: | ||
| Cash paid for interest | $2,971 | $2,773 |
| Cash paid for income taxes | 190 | 148 |
| Supplemental non-cash investing and financing activities: | ||
| Purchase of property and equipment included in liabilities | $7,072 | $20,629 |
The following presents our cash, cash equivalents and restricted cash by category in the Condensed Consolidated Balance Sheets:
| Fiscal Years-to-Date Ended | ||
|---|---|---|
| June 29, 2025 | June 30, 2024 | |
| Cash and cash equivalents | $135,978 | $235,103 |
| Restricted cash included in prepaid expenses, other current assets and other assets, non-current | 2,071 | 1,872 |
| Total cash, cash equivalents, and restricted cash | $138,049 | $236,975 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.